ConductScience.org, home

Paper9820175

Potent and non-specific inhibition of cytochrome P450 by JM216, a new oral platinum agent.

Ando Y and 6 others. Br J Cancer, 1998. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Potent and non-specific inhibition of cytochrome P450 by JM216, a new oral platinum agent. Papers, record 9820175. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9820175

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Potent and non-specific inhibition of cytochrome P450 by JM216, a new oral platinum agent.
PubMed
Journal
Br J Cancer
PubMed
Year
1998
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2019-05-15
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ando YY
2Shimizu TT
3Nakamura KK
4Mushiroda TT
5Nakagawa TT
6Kodama TT
7Kamataki TT

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Cytochrome P-450 Enzyme InhibitorsMajor topic
Enzyme InhibitorsMajor topic
Organoplatinum CompoundsMajor topic
Cytochrome P-450 Enzyme System
Humans
Hydroxylation
Kinetics
Microsomes, Liver
Paclitaxel
Testosterone

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17028434Inhibitors of Cytochrome P-450s and their mechanism of action.Drug Metab Rev1981https://conductscience.org/library/papers/7028434PubMed
29137529Combination chemotherapy involving orally administered etoposide and JM-216 in murine tumor models.Cancer Chemother Pharmacol1997https://conductscience.org/library/papers/9137529PubMed
33997827Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid.J Biol Chem1985https://conductscience.org/library/papers/3997827PubMed
43729972The nature of microsomal monooxygenase inhibition by cimetidine.Biochem Pharmacol1986https://conductscience.org/library/papers/3729972PubMed
53259858Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme.Arch Biochem Biophys1988https://conductscience.org/library/papers/3259858PubMed
63263862Inhibition of human hepatic and placental xenobiotic monooxygenases by imidazole antimycotics.Biochem Pharmacol1988https://conductscience.org/library/papers/3263862PubMed
72572912Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients.Lancet1989https://conductscience.org/library/papers/2572912PubMed
81648142Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer.J Natl Cancer Inst1991https://conductscience.org/library/papers/1648142PubMed
91784230Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function.Methods Enzymol1991https://conductscience.org/library/papers/1784230PubMed
101381906Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation.Arch Biochem Biophys1992https://conductscience.org/library/papers/1381906PubMed
118388318Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.Cancer Res1993https://conductscience.org/library/papers/8388318PubMed
128242617Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.Cancer Res1993https://conductscience.org/library/papers/8242617PubMed
137903909Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation.Cancer Res1994https://conductscience.org/library/papers/7903909PubMed
148114683O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.Mol Pharmacol1994https://conductscience.org/library/papers/8114683PubMed
158137461Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylates.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8137461PubMed
167913410Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme.Cancer Res1994https://conductscience.org/library/papers/7913410PubMed
177923194Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8.Cancer Res1994https://conductscience.org/library/papers/7923194PubMed
187575674Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia.Biochem Pharmacol1995https://conductscience.org/library/papers/7575674PubMed
197494563Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.N Engl J Med1996https://conductscience.org/library/papers/7494563PubMed
208640817Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.Cancer Res1996https://conductscience.org/library/papers/8640817PubMed

See all 26 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42819598Icariin: from preclinical promise to clinical reality-a critical evidence-based assessment.Front Pharmacol2026https://conductscience.org/library/papers/42819598PubMed
25556988Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors.Pediatr Blood Cancer2015https://conductscience.org/library/papers/25556988PubMed
19888874Satraplatin: leading the new generation of oral platinum agents.Expert Opin Investig Drugs2009https://conductscience.org/library/papers/19888874PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP1A11543PubTator's text mininghttps://conductscience.org/library/genes/1543NCBI Gene
CYP1A21544PubTator's text mininghttps://conductscience.org/library/genes/1544NCBI Gene
CYP2A61548PubTator's text mininghttps://conductscience.org/library/genes/1548NCBI Gene
CYP2C81558PubTator's text mininghttps://conductscience.org/library/genes/1558NCBI Gene
CYP2D61565PubTator's text mininghttps://conductscience.org/library/genes/1565NCBI Gene
CYP2E11571PubTator's text mininghttps://conductscience.org/library/genes/1571NCBI Gene
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9820175

GET https://conductscience.org/api/papers/v1/9820175/references?page=2